ESGO 2024: Oral presentation

Oral presentation at ESGO 2024
"Benefit From Atezolizumab In Patients With A Poor Prognostic Ovarian Cancer In First-Line Setting: IMAGYN 050 Trial" 
Speaker: Benoit You
Session Date: 8 March 2024
Session Time: 10:55-11:55